Advertisement

Topics

Lonza Group Ltd Company Profile

15:18 EDT 24th September 2018 | BioPortfolio

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality-minded production. Creative thinking, dedicated staff and sound resources are the strengths that Lonza relies on for further growth. Our people are the key to success – they have extensive expertise in multidisciplinary project management, integrating the wishes and know-how of our customers at every stage.

Location

Muenchensteinerstrasse 38
Basel
CH-4002
Switzerland

Contact

Phone: 41 61 316 81 11
Fax: 41 61 316 91 11
Email: info@lonza.com


News Articles [708 Associated News Articles listed on BioPortfolio]

Lonza Group Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

Lonza Group Ltd Strategy, SWOT and Corporate Finance ReportSummaryLonza Group Ltd Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report c...

Denali, Lonza collaborate on biologics for neurodegenerative diseases

Denali Therapeutics Inc. is collaborating with Lonza Group Ltd. to advance Denali’s biologic pipeline of neurodegenerative disease compounds through all stages of development and manufacturing.

Lonza Unit Launches Colorista Capsule to Cut Down on Development Time

NewsCapsugel Colorista capsules allow for flexibility to progress with technical development before the final commercial color decision is taken.

New Lonza biotech facility in Pearland changes hands

Zeller Realty Group has purchased the Lonza Viral Therapy Facility, a 276,770-square-foot biotechnology facility at 14905 Kirby Drive in Pearland, from Pinchal & Co. HFF handled the transaction.

Lonza Reports Positive Start to 2018

Lonza had a positive start to 2018 led by the businesses along the healthcare continuum. The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, has shown a strong ...

Lonza Launches New Bioscience Website

Lonza Bioscience is inviting visitors to explore its new dedicated website: bioscience.lonza.com. Filled with detailed application and product information, the website has been designed to support the...

Lonza Opens Cell and Gene Therapy Facility in Pearland, TX

Lonza today will officially open what it says is the world’s largest dedicated cell-and-gene-therapy facility in the Houston suburb of Pearland, TX. Executives from Lonza will join other dignita...

Lonza opens world’s largest gene therapy manufacturing plant in Texas

Swiss drug manufacturer Lonza has opened a ‘state-of-the-art’ cell and gene therapy manufacturing facility, the Lonza Houston Center of Excellence....Read More... The post Lonza opens world’s la...

PubMed Articles [1734 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Nephroprotective Effect of Zingerone against CCl-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

The protective effects of Zingerone against CCl induced nephrotoxicity in Swiss albino mice via modulation of metabolizing enzyme, oxidative stress, inflammatory cytokines, and apoptosis. The biochemi...

Clinical Trials [3919 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Companies [1634 Associated Companies listed on BioPortfolio]

LONZA Biologics plc

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality...

Lonza Group Ltd

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality...

Lonza Inc.

Basel, 17.05.2006 - Lonza Group announces the acquisition of assets which comprise Larex, Inc.’s Larch Arabinogalactan business. This strategic acquisition includes among other things, intellectual...

Akouos

Akouos is a precision genetic medicine company developing gene therapies that restore and preserve hearing. Leveraging its adeno-associated viral vectors (AAV)-based gene therapy ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

More Information about "Lonza Group Ltd" on BioPortfolio

We have published hundreds of Lonza Group Ltd news stories on BioPortfolio along with dozens of Lonza Group Ltd Clinical Trials and PubMed Articles about Lonza Group Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lonza Group Ltd Companies in our database. You can also find out about relevant Lonza Group Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record